A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference29 articles.
1. Treatment of metastatic disease, hormonal therapy and chemotherapy;Honing,1996
2. A systematic overview of chemotherapy effects in breast cancer;Bergh;Acta Oncol,2001
3. Chemotherapy: what progress in the last 5 years?;Hamilton;J Clin Oncol,2005
4. Antitumour antibiotic-containing regimens for metastatic breast cancer;Lord;Cochrane Database Syst Rev,2004
5. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193);Sledge;J Clin Oncol,2003
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current status of nanomedicine for breast cancer treatment;Targeted Nanomedicine for Breast Cancer Therapy;2022
2. Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer;Cancers;2021-09-01
3. Fever and breast cancer: A critical review of the literature and possible underlying mechanisms;Breast Disease;2021-07-15
4. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer;Therapeutic Advances in Medical Oncology;2021-01
5. Nonpeghylated liposomal doxorubicin combination regimen ( R‐COMP ) for the treatment of lymphoma patients with advanced age or cardiac comorbidity;Hematological Oncology;2020-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3